Champions Oncology (CSBR) EBT Margin Growth (1y) (2011 - 2026)
Champions Oncology (CSBR) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Champions Oncology |
78.46 Mn |
71.46 Mn |
13.89 Mn |
-2,795.00 |
| Date | Value |
|---|
| Jan 31, 2026 |
-2,795.00 |
| Oct 31, 2025 |
-378.00 |
| Jul 31, 2025 |
-1,272.00 |
| Apr 30, 2025 |
-1,454.00 |
| Jan 31, 2025 |
4,747.00 |
| Oct 31, 2024 |
2,328.00 |
| Jul 31, 2024 |
2,969.00 |
| Apr 30, 2024 |
1,808.00 |
| Jan 31, 2024 |
-200.00 |
| Oct 31, 2023 |
-1,779.00 |
| Jul 31, 2023 |
-1,801.00 |
| Apr 30, 2023 |
-1,675.00 |
| Jan 31, 2023 |
-2,501.00 |
| Oct 31, 2022 |
-247.00 |
| Jul 31, 2022 |
-79.00 |
| Apr 30, 2022 |
338.00 |
| Jan 31, 2022 |
-296.00 |
| Oct 31, 2021 |
229.00 |
| Jul 31, 2021 |
-233.00 |
| Apr 30, 2021 |
1,763.00 |
